1.
Bioorg Med Chem
; 41: 116212, 2021 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34000507
RESUMO
Respiratory infections resulting from pulmonary inflammation emerging as a leading cause of death worldwide. However, only twenty-seven new drugs were approved in the last five decades. In this review, we presented synthetic approaches for twenty-seven FDA-approved medications used to treat asthma and chronic obstructive pulmonary diseases (COPD), along with their mode of action.